Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association.

  title={Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association.},
  author={Salim S. Virani and {\'A}lvaro Alonso and Hugo J. Aparicio and Emelia J. Benjamin and M{\'a}rcio Sommer Bittencourt and Clifton Callaway and April P. Carson and Alanna M. Chamberlain and Susan Cheng and Francesca N. Delling and Mitchell S. V. Elkind and Kelly R. Evenson and Jane F. Ferguson and Deepak K. Gupta and Sadiya Sana Khan and Brett M. Kissela and Kristen L. Knutson and Chong-Do Lee and Ten{\'e} T. Lewis and Junxiu Liu and Matthew Shane Loop and Pamela L. Lutsey and Jun Ma and Jason Mackey and Seth Shay Martin and David Bruce Matchar and Michael E. Mussolino and Sankar D Navaneethan and Amanda M. Perak and Gregory A. Roth and Zainab Samad and Gary M. Satou and Emily B. Schroeder and Svati H Shah and Christina M. Shay and Andrew C. Stokes and Lisa B. VanWagner and Nae-Yuh Wang and Connie W Tsao},
BACKGROUND The American Heart Association, in conjunction with the National Institutes of Health, annually reports the most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health behaviors (smoking, physical activity, diet, and weight) and health factors (cholesterol, blood pressure, and glucose control) that contribute to cardiovascular health. The Statistical Update presents the latest data on a range of major clinical heart and… 
Gender Differences in Atherosclerotic Vascular Disease: From Lipids to Clinical Outcomes
The present review discusses the effects of gender and age on atherosclerotic processes, disease development, and clinical manifestations and the metabolic basis for the development of atherosclerosis appears to be related to sex hormones.
Diet and Lifestyle Factors and Risk of Atherosclerotic Cardiovascular Disease—A Prospective Cohort Study
The present study strengthens current recommendations of improving diet quality and increasing physical activity in preventing ACVD by linking high diet score and high leisure-time physical activity with increased risk of incident ACVD.
Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement.
A systematic review on the effectiveness of aspirin to reduce the risk of CVD events, cardiovascular mortality, and all-cause mortality in persons without a history of CVB concludes with moderate certainty that initiating aspirin use for the primary prevention of CVC events in adults 60 years or older has no net benefit.
New in the diagnosis of heart failure and management of associated conditions in 2021 ESC guidelines
Heart failure (HF) is a major health problem affecting millions of people worldwide. The r report about heart disease and stroke statistics claimed that almost 6.0 million Americans ≥20 years of age
Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association
There is emerging evidence that reducing blood pressure treatment goals in pregnancy may reduce maternal severe hypertension without increasing the risk of pregnancy loss, high-level neonatal care, or overall maternal complications.
The Diabetes-Cardiovascular Connection in Women: Understanding the Known Risks, Outcomes, and Implications for Care
Women with diabetes are at greater relative risk for CVD complications than men, with poorer outcomes, superimposed on preexisting gender disparities in social determinants of health, lower likelihood of being offered cardioprotective interventions, and enrollment in trials.
Cerebrovascular Disease and Statins
The evidence, use and recommendations of statins in the primary and secondary prevention of stroke, and their role in other scenarios such as the acute phase of ischemic stroke, cerebral hemorrhage, cardioembolic stroke, small vessel disease, and cognitive impairment are discussed.
Epidemiology of Peripheral Artery Disease and Polyvascular Disease
This review highlights important new advances in the epidemiology of PAD with a particular focus on polyvascular disease, emerging biomarkers, and differential risk pathways for PAD compared with other atherosclerotic diseases.